Provides cloud software that analyzes genomic and other health data for healthcare providers, research laboratories and biopharmaceutical companies.
20-F for FY2025, filed Mar 3, 2026
Healthcare providers, research laboratories and biopharmaceutical companies use its platform. The company sells directly and through distributors, and works with other healthcare providers to assemble solutions for customers.
20-F for FY2025, filed Mar 3, 2026
No. It lost $79M in .
20-F for FY2025, filed Mar 3, 2026
Radiomics added to CarePath
The older report described CarePath as a multimodal module and said radiomics would be integrated later; the latest report says CarePath incorporates the radiomics offering and is deployed in its Digital Twins research tool.
20-F for FY2022, filed Mar 7, 2023 20-F for FY2025, filed Mar 3, 2026In 2014, we launched the first application of our platform to analyze NGS data for cancer diagnosis. We offer a broad range of applications…View ↗
In 2014, we launched the first application of our platform to analyze NGS data for cancer diagnosis. We offer a broad range of applications…View ↗
Competes with Tempus Labs, F. Hoffmann-La Roche, Caris Life Sciences, Siemens, Koninklijke Philips, Konika Minolta, Agilent, Fabric Genomics, Illumina, Qiagen Digital Insights, Velsera, Congenica, and Thermo Fisher
20-F for FY2025, filed Mar 3, 2026We operate in a market characterized by rapidly advancing technologies and a strong emphasis on intellectual property. Our main competitors…View ↗
Loading...